R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,125 shares at $10.47 ($32K) on 2022-07-08, disclosed to the SEC on 2022-07-08.
Scheduled sale ($32k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.53 | 825 | $8K | 24.6% |
| 2 | $10.47 | 2,300 | $24K | 75.4% |
| Total | $10.22 avg | 3,125 | $32K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-04-08 | $11K | — | Filing → |